Cost analysis for different sequential treatment regimens for metastatic renal cell carcinoma in China
Guohai Shi(Shanghai Medical College of Fudan University), Xīn Gào(Qingdao University), Xiaolin Lü(Harbin Medical University), Peng Dong(Pfizer (China)), Mei Xue, Sang Hee Park(Pharmerit (United States)), Hongye Ren(Zhongda Hospital Southeast University)
Cited by 27
Related Papers
Aberrant CpG-island methylation has non-random and tumour-type–specific patterns
|Nature Genetics|2000|1.4k
Essential requirement for two-pore channel 1 in NAADP-mediated calcium signaling
|The Journal of Cell Biology|2009|406
Regulatory Role of G Protein–Coupled Estrogen Receptor for Vascular Function and Obesity
|Circulation Research|2009|366
Prostate Cancer, Version 3.2024
|Journal of the National Comprehensive Cancer Network|2024|289